Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

New heterocyclic compounds from Procter & Gamble particularly useful for alopecia

May 5, 2000

Transgenic antibody production agreement signed by Genzyme Transgenics and Abgenix

May 5, 2000

Gliatech submits ADCON-P preclinical module to FDA

May 4, 2000

Dapsone topical gel progresses through the pipeline for acne and itch

April 28, 2000

Successful application of antedrug approach to the development of topical antiinflammatory agents

April 27, 2000

Abbott and Chrysalis BioTechnology collaborate on Chrysalin development

April 26, 2000

Faulding obtains Australian rights to ConXn

April 19, 2000

Apligraf PMA supplement tentatively scheduled for FDA review in May

April 11, 2000

New compounds from Japanese lab inhibit Th2-type cytokine production

April 7, 2000

FDA gives go-ahead for Access to commence OraDisc clinical trials

April 5, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...